Several authors in recent years have demonstrated the involvement of specific VASP phosphorylation sites to cardiac dysregulation with, S157 and S239 phosphorylation mediating cardiac hypertrophy and Rac-1 mediated actin cytoskeletal remodelling during pulmonary endothelial cell barrier formation [50,51]. This evidence concerns the gene VASP and cardiac hypertrophy.